GENERIC NAME OF THE MEDICINAL PRODUCT:

a) Quinupristin And Dalfopristin Dry Powder for Injection (Lyophilized) 500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Quinupristin And Dalfopristin Dry Powder for Injection (Lyophilized) 500mg
Each vial contains:
Sterile lyophilized quinupristin ………………150mg
dalfopristin…………………………………….350mg
Excipients……………………………………..q.s.

THERAPEUTIC INDICATIONS:

Quinupristin-dalfopristin is indicated for the treatment of serious infections caused by MDR organisms, VREF, and MRSA, including soft tissue infections, pneumonia, and bacteremia.

CAUTION & SCHEDULE:

CAUTION: It is Dangerous to take this preparation Except in accordance with the medical advice.
SCHEDULE: Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Prior to Reconstitution: Refrigerate 2°-8°C (36°-46°F).
After Reconstitution: The solution must be immediately transferred to 250 mL of dextrose solution.
The diluted solution maintains satisfactory potency for 5 hours at 20°-25°C (68°-77°F) or for 54 hours in a refrigerator 2°-8°C.
Dosage: See package insert for dosage information.
As directed by Physician

Quinupristin And Dalfopristin Dry Powder for Injection (Lyophilized) 500mg Technical Specification:

Product Name:Quinupristin And Dalfopristin Dry Powder for Injection (Lyophilized) 500mg
Brand Name:Generics
Strength:500mg
Dosage Form:Dry Powder Injection (Sterile)
Packing:LYOPHILIZED Powder
Route of Administration:FOR IV USE Only-Not for Direct Infusion 1 Sterile Vial.
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Antibacterial
Indication: Quinupristin-dalfopristin is indicated for the treatment of serious infections caused by MDR organisms, VREF, and MRSA, including soft tissue infections, pneumonia, and bacteremia.
Storage:Store Protected from moisture at a temperature not exceeding 30°C

GENERIC NAME OF MEDICINAL PRODUCT:

  • Quinupristin And Dalfopristin Dry Powder for Injection (Lyophilized) 500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

Quinupristin And Dalfopristin Dry Powder for Injection (Lyophilized) 500mg
Each vial contains:
Sterile lyophilized quinupristin ………………150mg
dalfopristin…………………………………….350mg
excipients……………………………………………..q.s.

THERAPEUTIC INDICATION:

Quinupristin-dalfopristin is indicated for the treatment of serious infections caused by MDR organisms, VREF, and MRSA, including soft tissue infections, pneumonia, and bacteremia.

CAUTION & SCHEDULE:

CAUTION:It is Dangerous to take this preparation Except in accordance with the medical advice.
SCHEDULE:Not to be sold by retail without the prescription of registered Medical Practitioner.

STORAGE & DOSAGE:

Storage:Prior to Reconstitution: Refrigerate 2°-8°C (36°-46°F).
After Reconstitution: The solution must be immediately transferred to 250 mL of dextrose solution
The diluted solution maintains satisfactory potency for 5 hours at 20°-25°C (68°-77°F) or for 54 hours in a refrigerator 2°-8°C.
Dosage:See package insert for dosage information.
As directed by Physician.